Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00939029 · ClinicalTrials.gov registry record · Phase 2
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
A Phase 2 study of Smokeless Tobacco Use, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT00939029 is a Phase 2 study of Smokeless Tobacco Use that has completed, run by Mayo Clinic. The registered enrollment target is 52 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00939029, a Phase 2 study of Smokeless Tobacco Use, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Smokeless tobacco use ("chewing") is associated with negative health effects. To date, no medications have been shown to help chewers quit long-term. High dose nicotine patch therapy may improve the chances that chewers can quit for good. If found to be effective, chewers may use this treatment to help them quit and reduce their risk for negative health effects.
Conditions Studied
Interventions
- DRUG nicotine replacement therapy (nicotine patches)
- DRUG placebo NRT
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00939029
The ClinicalTrials.gov registry entry for NCT00939029 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smokeless Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which nicotine replacement therapy (nicotine patches) is the first listed.
NCT00939029 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00939029 about?
NCT00939029 is a clinical study titled "Highdose Nicotine Patch Therapy for Smokeless Tobacco Use". Smokeless tobacco use ("chewing") is associated with negative health effects. To date, no medications have been shown to help chewers quit long-term. High dose nicotine patch therapy may improve the chances that chewers can quit for good. If found to be effective, chewers may use this treatment to h...
What is the current status of trial NCT00939029?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2010-07. Estimated completion is 2013-06.
What conditions does trial NCT00939029 study?
This clinical trial studies the following conditions: Smokeless Tobacco Use.
What interventions are being tested in trial NCT00939029?
The interventions under investigation include: nicotine replacement therapy (nicotine patches) (DRUG), placebo NRT (DRUG).
Who is sponsoring clinical trial NCT00939029?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00939029 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.